Content about Antibiotic resistance

March 10, 2014

The majority of pediatric bacterial infections that cause severe diarrhea and are potentially life-threatening occur among children who recently took antibiotics prescribed by doctors for other conditions, according to a new study by the Centers for Disease Control and Prevention published this week in Pediatrics.

NEW YORK — The majority of pediatric bacterial infections that cause severe diarrhea and are potentially life-threatening occur among children who recently took antibiotics prescribed by doctors for other conditions, according to a new study by the Centers for Disease Control and Prevention published this week in Pediatrics.

January 16, 2014

A faculty member at Southern Illinois University Edwardsville has been awarded a United States patent for an invention that tackles bacterial contamination.

EDWARDSVILLE, Ill. — Dr. Ronald Worthington, associate professor of pharmaceutical sciences at the School of Pharmacy at Southern Illinois University Edwardsville, obtained U.S. Patent No. 8,563,293 for his invention to protect against bacterial contamination. 

December 16, 2013

The Food and Drug Administration may require makers of antibacterial soaps to perform clinical trials to show their products are better at preventing infections and disease than ordinary soaps.

SILVER SPRING, Md. — The Food and Drug Administration may require makers of antibacterial soaps to perform clinical trials to show their products are better at preventing infections and disease than ordinary soaps, part of a larger effort by the agency to ensure the safety and efficacy of antibacterial products and slow down the rise of antibiotic-resistant bacteria.

December 11, 2013

The Food and Drug Administration is planning to limit the use of antimicrobials in food animals in an effort to stem the rise of antibiotic-resistant bacteria, the agency said Wednesday.

SILVER SPRING, Md. – The Food and Drug Administration is planning to limit the use of antimicrobials in food animals in an effort to stem the rise of antibiotic-resistant bacteria, the agency said Wednesday.

October 7, 2013

Doctors have continued prescribing antibiotics for mild conditions that don't require them despite decades of efforts by government authorities to discourage the practice, according to a new study.

NEW YORK — Doctors have continued prescribing antibiotics for mild conditions that don't require them despite decades of efforts by government authorities to discourage the practice, according to a new study.

September 17, 2013

Antibiotic-resistant bacteria sicken more than 2 million people per year and kill at least 23,000, according to a new study by the Centers for Disease Control and Prevention.

ATLANTA — Antibiotic-resistant bacteria sicken more than 2 million people per year and kill at least 23,000, according to a new study by the Centers for Disease Control and Prevention.

And the costs go beyond human health and life. According to a study by Tufts University, direct healthcare costs and costs to society for lost productivity from the infections could be as high as $55 billion per year.

January 10, 2013

A recent study found that poor heath literacy among Latino parents is associated with incorrect beliefs on the proper use of antibiotics, particularly for upper respiratory infections, which can lead to an increase in antimicrobial resistance.

NEW YORK — A recent study found that poor heath literacy among Latino parents is associated with incorrect beliefs on the proper use of antibiotics, particularly for upper respiratory infections, which can lead to an increase in antimicrobial resistance.

September 24, 2012

The Food and Drug Administration is creating a new task force to support the development of new drugs for bacterial infections, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration is creating a new task force to support the development of new drugs for bacterial infections, the agency said Monday.

The FDA said the Antibacterial Drug Development Task Force would assist in developing and revising guidance related to development of antibiotics, as required by the Generating Antibiotic Incentives Now Title of the FDA Safety and Innovation Act, which president Barack Obama signed into law on July 9.

September 10, 2012

A drug maker and medical research institute will work together to identify new treatments for bacterial and viral infections.

CAMBRIDGE, Mass. — A drug maker and medical research institute will work together to identify new treatments for bacterial and viral infections.

AstraZeneca and the Broad Institute, owned jointly by Harvard University and MIT, announced Monday that they would collaborate for two years to develop medicines to treat severe infections, saying the identification of high-quality chemicals for the development of new drugs was a significant challenge. The two will use the Broad Institute's collection of 100,000 chemicals known as diversity-oriented synthesis, or DOS compounds.

September 14, 2011

A new resistant strain of methicillin-resistant staphylococcus aureus may be on the rise due to the frequent use of over-the-counter antibacterial ointments, according to a study to be published in the October issue of Emerging Infectious Diseases.

ATLANTA — A new resistant strain of methicillin-resistant staphylococcus aureus may be on the rise due to the frequent use of over-the-counter antibacterial ointments, according to a study to be published in the October issue of Emerging Infectious Diseases.

As reported by CNN.com, Japanese researchers made the finding after testing 259 MRSA strains for susceptibility to bacitracin and neomycin, two of the antibacterial ingredients commonly found in such OTC ointments as Neosporin and Polysporin.

April 21, 2011

The Food and Drug Administration on Wednesday issued four warning letters to companies that manufacture and market over-the-counter drug products, including hand sanitizers, that claim to prevent infection from methicillin-resistant Staphylococcus aureus bacteria, or MRSA.

SILVER SPRING, Md. — The Food and Drug Administration on Wednesday issued four warning letters to companies that manufacture and market over-the-counter drug products, including hand sanitizers, that claim to prevent infection from methicillin-resistant Staphylococcus aureus bacteria, or MRSA.

March 10, 2011

A lawmaker from New York has introduced legislation designed to combat the rise of antibiotic-resistant bacteria.

WASHINGTON — A lawmaker from New York has introduced legislation designed to combat the rise of antibiotic-resistant bacteria.

Keep Antibiotics Working, a Chicago-based organization, praised the Preservation of Antibiotics for Medical Treatment Act, introduced by Rep. Louise Slaughter, D-N.Y.

October 31, 2010

The Food and Drug Administration has approved a new treatment for bacterial infections made by...

NEW YORK The Food and Drug Administration has approved a new treatment for bacterial infections made by Forest Labs, Forest said.

The drug maker announced the approval of Teflaro (ceftaroline fosamil) for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection, also known as ABSSSI, caused by bacteria that include methicillin-resistant Staphylococcus aureaus.